Fatal Epstein-Barr Virus Primo Infection in a 25-Year-Old Man Treated with Azathioprine for Crohn's Disease-Reference-Cited by-同舟云学术

Fatal Epstein-Barr Virus Primo Infection in a 25-Year-Old Man Treated with Azathioprine for Crohn's Disease

Published:2009-04 Issue:4 Volume:47 Page:1252-1254
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

N'Guyen Y.¹,Andreoletti L.²,Patey M.³,Lecoq-Lafon C.⁴,Cornillet P.⁵,Léon A.⁶,Jaussaud R.¹,Fieschi C.⁷,Strady C.¹

Affiliation:

1. Service de Médicine Interne et des Maladies Infectieuses, Hôpital Robert Debré-CHU Reims, Reims, France

2. Laboratoire de Virologie Médicale et Moléculaire, EA4303/IFR53, CHU Reims, Hôpital Robert Debré, Reims, France

3. Laboratoire d'Anatomo-pathologie, Hôpital Robert Debré-CHU Reims, Avenue du Général Koenig, Reims, France

4. Laboratoire d'Hématologie, Hôpital Robert Debré-CHU Reims, Avenue du Général Koenig, Reims, France

5. Laboratoire de Cytogénétique, Hôpital Maison-Blanche-CHU Reims, Reims, France

6. Département d'Anesthésie-Réanimation, Hôpital Robert Debré-CHU Reims, Reims, France

7. Unité d'Immunopathologie, Département d'Immunologie Clinique, EA3963 Centre Hayem, Hôpital Saint Louis, 75010 Paris, France

Abstract

ABSTRACT We report a case of Epstein-Barr virus (EBV) primo infection with the development of successive infectious mononucleosis, hemophagocytic lymphohistiocytosis, and B-cell lymphoproliferative disorder in a patient treated with azathioprine for Crohn's disease. This case report suggests that specific EBV-related clinical and virological management should be considered when treating a patient with inflammatory bowel disease with azathioprine.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.02052-08

Reference17 articles.

1. Aubin, J., F. Davi, F. Nguyen-Salomon, D. Leboeuf, C. Debert, M. Taher, F. Valensi, D. Canioni, N. Brousse, and B. Varet. 1995. Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia9:471-479.

2. Chan, J. K. 2001. The new World Health Organization classification of lymphomas: the past, the present and the future. Hematol. Oncol.19:129-150.

3. Dayharsh, G. A., E. V. Loftus, Jr., W. J. Sandborn, W. J. Tremaine, A. R. Zinsmeister, T. E. Witzig, W. R. Macon, and L. J. Burgart. 2002. Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. Gastroenterology122:72-77.

4. Farrell, R. J., Y. Ang, P. Kileen, D. S. O'Briain, D. Kelleher, P. W. Keeling, and D. G. Weir. 2000. Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut47:514-519.

5. Garrido Serrano, A., F. Pérez Martín, F. J. Guerrero Igea, J. Galbarro Muñoz, and S. Palomo Gil. 2000. Fatal infectious mononucleosis during azathioprine treatment in Crohn's disease. Gastroenterol. Hepatol.23:7-8. (In Spanish.)

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009;Zeitschrift für Gastroenterologie;2023-08

2. Vitreoretinal Lymphoma in a Patient with Rheumatoid Arthritis with a History of Methotrexate-associated Lymphoproliferative Disorders;Ocular Immunology and Inflammation;2022-11-17

3. Impact of Epstein–Barr virus infection in patients with inflammatory bowel disease;Frontiers in Immunology;2022-10-28

4. Use of thiopurines in inflammatory bowel disease: an update;Intestinal Research;2022-01-30

5. Immunomodulators: still having a role?;Gastroenterology Report;2022-01-01